Q&A With Hayes Dansky From Janssen Pharmaceuticals: Using Xarelto to Treat Venous Thromboembolism In Everyday Practice

Video

Venous thromboembolism is a serious condition that requires a high level of care and treatment. A recent study looked at how the prescribing of Xarelto has helped the treatment process.

Venous thromboembolism (VTE) is a serious condition that requires a high level of care and treatment. A recent study looked at how the prescribing of Xarelto has helped the treatment process.

Hayes Dansky, MD, from Janssen Pharmaceuticals discussed the condition which affects almost 900,000 people in America every year during the annual meeting of the American Society of Hematology in Orlando. Dansky's presentation focused on the Xalia study which looked at how the medicationw as was being used in real world patient care and how effective it was in helping this patient population.

Related Videos
Kelley Branch, MD, MS | Credit: University of Washington Medicine
David Berg, MD, MPH | Credit: Brigham and Women's
HCPLive Five at ACC 2024 | Image Credit: HCPLive
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit: X.com
Heart Failure stock imagery. | Credit: Fotolia
© 2024 MJH Life Sciences

All rights reserved.